Emagix's generative AI aims to reduce vision loss caused by delayed treatment of retinal diseases.
Individuals with retinal disease caused by old age or diabetes require intervention once the blood vessels in their retina become leaky.
Until now, detection of retinal leakage was only possible through an invasive exam that involves an intravenous injection of a dye.
Emagix’s generative AI simulates this invasive exam from a standard-of-care non-invasive exam, eliminating the need for dye injection.
This solution will allow widespread screening for early signs of retinal leakage and timely intervention to prevent vision loss.
Company Details
- Employees
- 5
- Address
- 1344 Summer St, Halifax,nova Scotia B3h 0a8,canada
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.emagix.ca/
- Keywords
- Halifax.
- HQ
- Halifax, Nova Scotia
Emagix Questions
Emagix's website is https://www.emagix.ca/
Emagix's LinkedIn profile is https://ca.linkedin.com/company/emagix
Emagix has
5 employees.
View email and phone details for 5
employees at Emagix.
Emagix's industry is
Medical Equipment Manufacturing
Emagix's top competitors are
Rfine Biomass Solutions,
Healtheme Inc.,
Altheda Wellness Innovation,
Enaimco,
Baskl.ai,
Ring Rescue Inc.,
Aruna Revolution,
Elle, Md Biotechnologies,
Think Self-Management,
Greenlight Analytical.
Emagix's categories are Medical Equipment Manufacturing
